NovaBridge Biosciences Accounts Payable and Accrued Liabilities, Noncurrent
NovaBridge Biosciences (NBP) had Accounts Payable and Accrued Liabilities, Noncurrent of CNY 69.66 million as of 2023-12-31, per its 20-F filed 2024-04-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:AccountsPayableAndAccruedLiabilitiesNoncurrent · last filed 2025-04-03
- 2023-12-31: Accounts Payable and Accrued Liabilities, Noncurrent 69.66M CNY.
- 2022-12-31: Accounts Payable and Accrued Liabilities, Noncurrent 16.96M CNY.
- 2022-06-30: Accounts Payable and Accrued Liabilities, Noncurrent 13.95M CNY.
- 2021-12-31: Accounts Payable and Accrued Liabilities, Noncurrent 14.93M CNY.
CNY
| Period end | Accounts Payable and Accrued Liabilities, Noncurrent |
|---|---|
| 2023-12-31 | 69.66M CNY 20-F · filed 2024-04-30 |
| 2022-12-31 | 16.96M CNY 20-F · filed 2024-04-30 |
| 2022-06-30 | 13.95M CNY 6-K · filed 2022-11-10 |
| 2021-12-31 | 14.93M CNY 20-F · filed 2023-05-01 |
| 2020-12-31 | 8.97M CNY 20-F · filed 2022-04-29 |
USD
| Period end | Accounts Payable and Accrued Liabilities, Noncurrent | Accounts Payable and Accrued Liabilities, Noncurrent as first filed |
|---|---|---|
| 2023-12-31 | $106.00K 20-F · filed 2025-04-03 | $9.81M 20-F · filed 2024-04-30 |
| 2022-12-31 | $2.46M 20-F · filed 2023-05-01 | |
| 2022-06-30 | $2.08M 6-K · filed 2022-11-10 | |
| 2021-12-31 | $2.34M 20-F · filed 2022-04-29 | |
| 2020-12-31 | $1.38M 20-F · filed 2021-04-28 |